Research on hippocampus capsule therapy of experimental benign prostatic hyperplasia

Chinese Pharmaceutical Journal

Volumn 40, Issue 3, 2005, Pages 190-193

  Meng, Xue Qiang ^a   Xu, Dong Hui ^a   Mei, Xue Ting ^a   Xu, Shi Bo ^a   Lü, Jun Yi ^a   Li, Bing Ji ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Z Richvast G Co Ltd   (China)

Author keywords

Experimental benign prostatic hyperplasia; Hippocampus capsule; Pharmacology

Indexed keywords

BIOLOGICAL ORGANS; BODY FLUIDS; DRUG THERAPY; KETONES; LIVING SYSTEMS STUDIES;

BENIGN PROSTATIC HYPERPLASIA (BPH); HIPPOCAMPUS CAPSULE THERAPY; RAT MODEL; UROGENITAL SINUS (UGS);

PHARMACODYNAMICS;

ACID PHOSPHATASE; HIPPOCAMPUS KUDA EXTRACT; NATURAL PRODUCT; NITRIC OXIDE; TESTOSTERONE PROPIONATE; UNCLASSIFIED DRUG; ZINC;

ACID PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTRATION; DRUG CAPSULE; DRUG EFFECT; DRUG EFFICACY; HIPPOCAMPUS KUDA; INVERTEBRATE; MALE; MOUSE; NONHUMAN; ORGAN WEIGHT; PROSTATE HYPERTROPHY; RAT; SEA HORSE; SEMINAL VESICLE; TUMOR MODEL; UROGENITAL SINUS; ZINC BLOOD LEVEL;

EID: 17444361848     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Takeda M, Tang R, Shapiro E, et al. Effects of nitric oxide on human and canine prostates[J]. Urology, 1995, 45:440.
2. Burnett AL, Lowenstein CJ, Bredt DS, et al. Nitric oxide: a physiologyic mediator of penile erection [J]. Science, 1992, 257(5068): 401.
3. Burnett AL , Maguire MP, Chamness SL, et al. Characterization and localization of nitric oxide synthase in the human prostate [J]. Urology, 1995, 45(3):435.
4. Klotz T, Bloch W, Loch C, et al. Verteilungs muster der konstitutiven isoformen der NO-synthase in der normalen prostateund der obstrukeiven Bredtprostatahyperplasie[J]. Urology A, 1997, 36(4):318.